Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul;78(11):1157-1161.
doi: 10.1007/s40265-018-0944-0.

Erenumab: First Global Approval

Anthony Markham  1
Affiliations
Review

Erenumab: First Global Approval

Anthony Markham. Drugs. 2018 Jul.

Abstract

Amgen and Novartis are developing erenumab (AIMOVIG™, erenumab-aooe)-a fully human monoclonal antibody calcitonin gene-related peptide (CGRP) receptor antagonist-for the prevention of migraine. CGRP is a vasodilatory neuropeptide implicated in the pathophysiology of migraine and treatment with erenumab was associated with significant reductions in migraine frequency in phase II and III clinical trials. Based on these positive results erenumab was recently approved in the US for the preventive treatment of migraine in adults and has received a positive opinion in the EU for the prophylaxis of migraines in adults who have at least 4 migraine days per month. This article summarizes the milestones in the development of erenumab leading to this first approval.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Clin Pharmacol Ther. 2018 May;103(5):815-825 - PubMed
    1. Lancet Neurol. 2017 Jun;16(6):425-434 - PubMed
    1. N Engl J Med. 2017 Nov 30;377(22):2123-2132 - PubMed
    1. Cephalalgia. 2018 May;38(6):1026-1037 - PubMed
    1. Neurology. 2017 Sep 19;89(12):1237-1243 - PubMed

MeSH terms

Substances

LinkOut - more resources